Jazz Prescribed drugs Publicizes Pricing of Non-public Providing of $850 Million of three.125% Exchangeable Senior Notes due 2030 and Concurrent Unusual Share Repurchases
DUBLIN, Sept. 4, 2024 /PRNewswire/ — Jazz Prescribed drugs plc (Nasdaq: JAZZ) (“ Jazz Prescribed drugs (NASDAQ:)“) right now introduced…
